WCN26-8054 CONTINUATION OF RAAS INHIBITORS DURING AKI: ASSOCIATED WITH LOWER MORTALITY AND ICU ADMISSION

Read full text Summarise with VIRAT
Authors: Shankar Kumar Biswas, Ayman Hamadttu, Yashasvi Srivastava, Elangovan Krishnan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The ideal management of renin-angiotensin-aldosterone system (RAAS) inhibitors following the onset of acute kidney injury (AKI) remains a topic of debate. Despite being routinely discontinued in clinical settings, the evidence supporting this practice is very limited. This study aims to determine whether continuation versus discontinuation of RAAS inhibitors during AKI is associated with differences in patient outcomes.

Fields of Study & Subjects

Acute Kidney Injury Research Renin-Angiotensin System Studies Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104024–104024
Publication date
25 March 2026
Language
EN